Oral thin films (OTF) are placed on or under the tongue or buccally. They are immediately absorbed by the oral mucosa and the active substance is directly transported into the bloodstream. Our technologies enable fast release of the active substance, measure between 2 and 10 cm² and are extremely thin (20 to 500 µm). Forms can be a single-layer or multi-layer system, with the active substance able to be dissolved in the matrix, emulsified or dispersed. It can also be bound as a complex in order to mask taste, for example. Our partners are currently utilizing our OTF technology for therapies including opioid use disorder, pain management and vomiting/nausea.